Hospital Clínico Universitario de Salamanca

Salamanca 37007

2 studies enrolling now · 13 studies all time

What they study most

AML, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Breast Cancer, COVID-19, Chronic Myelomonocytic Leukemia, Covid19, Heart Failure, Indolent Non-Hodgkin's Lymphomas, Leukemia, Myeloid, Acute, MDS, Mantle Cell Lymphoma

Studies at this site

• Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation — Completed
• Alleviant ALLAY-HFrEF Study — Enrolling by invitation
• Alleviant ALLAY-HF Study — Enrolling by invitation
• Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE — Completed
• SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction — Completed
• MP1032 Treatment in Patients With Moderate to Severe COVID-19 — Completed
• Efficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AML — Stopped early
• Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients — Completed
• (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive — Completed
• Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts — Completed
• A Study to Evaluate the Efficacy of Lenalidomide as Maintenance Therapy After Completion of First-line Combination Chemotherapy in Patients With Mantle Cell Lymphoma (MCL). — Stopped early
• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas — Stopped early
• Trial of Myocet in Metastatic Breast Cancer — Status unconfirmed